Skip to main content

Mothers May Be Key Source of LOD Strep in Neonates


Mothers appear to be the source of most neonatal group BStreptococcus (GBS) late-onset disease (LOD) infections, according to a the results of a prospective cohort study. In addition, preterm neonates have a high rate (1.4/1000 births) of group B Streptococcus (GBS) late-onset disease (LOD). They also carry the highest rate of mortality. Intrapartum antibiotics are associated with milder LOD (mild vs severe; P = .03) and delayed presentation of symptoms.
Alberto Berardi, MD, from the Azienda Ospedaliero-Universitaria Proclinico in Moddena, Italy, and colleagues published the results of their online January 7 in Pediatrics. They evaluated GBS-LOD infections during an 8-year period between 2003 and 2010. The study included a high percentage of preterm newborns.
LOD primarily presented as sepsis, meningitis, and/or focal infection. The investigators found that the earlier the presentation of LOD, the higher the risk for meningitis and death.
Approximately 50% of the preterm infants who were diagnosed with LOD were diagnosed as inpatients. This population had lower birth weight, younger gestational age, and more severe disease.
The rate of GBS-LOD in full term neonates was 0.24 per 1000 live births.
At the time of neonatal diagnosis, the authors found that most mothers (64%) carried GBS and some (6%) had mastitis.
Previous case reports have suggested that infected breast milk (even in the absence of mastitis) may be a cause of LOD. The authors also identified GBS-infected milk as a source of infection, noting that in some cases the milk was infected even if the mother did not have mastitis. The authors point out, however, that bacterial counts of milk cultures were not routinely available for mothers without mastitis.
One third of mothers who were screened antenatally and at the time of LOD diagnosis were culture-negative. More than half of women who were identified by screening as GBS-positive received antibiotics, and yet many women went on to transmit the organism to their infants.
Lately, there have been few reports of GBS outbreaks. The authors, however, note that population-based reports on GBS vary a great deal. Most studies agree that low birth weight is associated with an increased risk for GBS infection. Few studies, however, have included a significant number of preterm neonates.
The research leading to these results received funding from the European Community’s Seventh Framework Programme. This study was also supported by the Italian Ministry of Health. The authors have disclosed no relevant financial relationships.

Comments

Post a Comment

Popular posts from this blog

Contact Precautions May Have Unintended Consequences

Contact precautions, including gloves, gowns, and isolated rooms, have helped stem the transmission of hospital pathogens but have also had some negative consequences, according to findings from a new study. Healthcare worker (HCWs) visited patients on contact precautions less frequently than other patients and spent less time with those patients when they did visit, report Daniel J. Morgan, MD, from the University of Maryland School of Medicine and the Veterans Affairs (VA) Maryland Health Care System, Baltimore, and colleagues. Moreover, patients on contact precautions also received fewer outside visitors. "Less contact with HCWs suggests that other unintended consequences of contact precautions still exist," Dr. Morgan and coauthors write. "The resulting decrease in HCW contact may lead to increased adverse events and a lower quality of patient care due to less consistent patient monitoring and poorer adherence to standard adverse event prevention methods (such...
Post a Comment
Read more

CareFusion Issues Update on Infant Breathing Product Recall

July 5, 2012 — Medical device maker CareFusion has issued an update reminding healthcare providers of its voluntary recall of its Air Life ™ Infant Breathing Circuit, initiated back in May. The US Food and Drug Administration (FDA) has classified this action as a class 1 recall, meaning there is a reasonable probability of serious adverse health consequences or death associated with use of the defective units. The update was posted July 2 on the FDA  Website. On May 29, 2012, CareFusion sent an  Urgent Recall Notice  to customers and distributors stating that the company had identified potential risks associated with the Air Life  Infant Breathing Circuit. The action was initiated after the company received complaints of the Y adapter within the breathing circuit developing cracks during patient use. "If a crack develops in the Y adapter, this could potentially result in a leak in the closed ventilation system, leading to a loss in the intended tidal volum...
Post a Comment
Read more

FDA Approves Tapentadol ER for Diabetic Neuropathy

August 29, 2012 — The US Food and Drug Administration (FDA) has approved tapentadol extended-release (ER) ( Nucynta , Janssen Pharmaceuticals, Inc) for the management of neuropathic pain associated with diabetic peripheral neuropathy (DPN) in adults for whom a continuous opioid analgesic is required over an extended time. It is the first opioid to receive this indication, the company notes in a statement today. DPN, the most common type of neuropathy, affects an estimated 16% of the more than 25 million Americans who have diabetes. The condition is often unreported and untreated, with an estimated 2 out of 5 cases not receiving care. Tapentadol ER is already approved for the treatment of moderate to severe chronic pain in adults requiring a continuous opioid analgesic for an extended period. It is a centrally acting synthetic analgesic, although the exact mechanism of action is unknown, the release states. "Although the clinical relevance is unclear," the company n...
4 comments
Read more